Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: PepTools vendor-neutral scientific reference catalog
Also known as: CX11
VCT220 is an investigational nonpeptide GLP-1 receptor agonist developed as an oral small-molecule compound. Authoritative clinical records identify CX11 as an alternative name for VCT220 and describe the investigational product as an oral film-coated tablet. A peer-reviewed phase II study reported pharmacodynamic effects consistent with GLP-1 receptor agonism, including reductions in body weight and improvements in selected metabolic measures in adults with overweight or obesity.
Source review pending. This descriptive profile is shown from the available source material as a best-effort educational reference. It has not passed the full verification bar and is not a dosing instruction, medical claim, or treatment recommendation.
Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
VCT220 remains an investigational compound in the authoritative records reviewed. Pharmacokinetic, physicochemical, formulation, and storage specifications were not reliably available from the reviewed noncommercial primary or registry sources. ClinicalTrials.gov records identify VCT220 as CX11 and describe oral tablet formulations.
Supplementary research context only. Not medical advice or a treatment recommendation.
VCT220; CX11
Public authoritative records reviewed do not provide a confirmed CAS Registry Number, molecular formula, molecular weight, SMILES, InChI, or publicly disclosed chemical structure for VCT220/CX11.
Reflects published research. Educational reference — not a recommendation for use.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Published articles on this site that mention VCT220 or one of its catalog aliases.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.